Human-human hybridoma, CLNH5

Details Human-human hybridoma, CLNH5 Human-human hybridoma, CLNH5

1983-02-09

1986-10-21

Kepplinger, Esther M.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 68, 4351722, 435240, 435948, 436548, 436813, 935 99, 935110, 530388, G01N 3353, C12P 2100, C12N 1500, C12N 500, C12R 191

Patent

active

046185771

ABSTRACT:
Novel hybridomas, human monoclonal antibodies, and their uses are provided. Specifically CLNH5 is a human-human hybridoma which secretes IgM monoclonal antibodies specific for cervical of carcinomas. The monoclonal antibodies can find use in therapy and diagnosis, both in vitro and in vivo.
The hybridoma CLNH5 was deposited at the A.T.C.C. for patent purposes as defined in M.P.E.P. 608.01(p) on Jan. 28, 1983 and given A.T.C.C. Accession No. HB8206.

REFERENCES:
patent: 3654090 (1972-04-01), Schuurs et al.
patent: 3927193 (1975-12-01), Hansen et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4350626 (1982-09-01), Masuho et al.
patent: 4359457 (1982-11-01), Neville, Jr. et al.
patent: 4361544 (1982-11-01), Goldenberg
patent: 4434230 (1984-02-01), Ritts, Jr.
patent: 4443427 (1984-04-01), Reinherz et al.
patent: 4451570 (1984-05-01), Royston et al.
patent: 4454106 (1984-06-01), Gansow et al.
Schlom et al. (1980) Generation of Human Monoclonal Antibodies Reactive with Mammary Carcinoma Cells, Proc. Natl. Acad. Sci., 77(11): 6841-6845.

Affiliated with

Also associated with

Rating

Human-human hybridoma, CLNH5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human-human hybridoma, CLNH5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human-human hybridoma, CLNH5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1289811